Perrigo Company PLC EVP Sharon Kochan Sells 1,116 Shares (PRGO)
Perrigo Company PLC (NASDAQ:PRGO) EVP Sharon Kochan sold 1,116 shares of the stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $150.00, for a total value of $167,400.00. Following the completion of the sale, the executive vice president now directly owns 5,400 shares of the company’s stock, valued at approximately $810,000. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Perrigo Company PLC (NASDAQ:PRGO) traded down 2.58% on Thursday, hitting $146.07. The stock had a trading volume of 885,635 shares. Perrigo Company PLC has a 1-year low of $122.12 and a 1-year high of $168.39. The stock has a 50-day moving average of $149. and a 200-day moving average of $148.7. The company has a market cap of $19.547 billion and a price-to-earnings ratio of 84.71.
Perrigo Company PLC (NASDAQ:PRGO) last posted its quarterly earnings results on Thursday, August 14th. The company reported $1.74 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.55 by $0.19. The company had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.09 billion. Analysts expect that Perrigo Company PLC will post $7.38 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Tuesday, September 16th. Investors of record on Friday, August 29th will be given a dividend of $0.105 per share. This represents a $0.42 dividend on an annualized basis and a yield of 0.29%. The ex-dividend date of this dividend is Wednesday, August 27th.
PRGO has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Perrigo Company PLC in a research note on Monday, August 18th. They now have a $156.00 price target on the stock. Separately, analysts at B. Riley upgraded shares of Perrigo Company PLC from a “neutral” rating to a “buy” rating in a research note on Friday, August 15th. They now have a $180.00 price target on the stock, up previously from $157.00. Finally, analysts at Jefferies Group raised their price target on shares of Perrigo Company PLC from $160.00 to $176.00 in a research note on Friday, August 15th. They now have a “buy” rating on the stock. Three equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $166.92.
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ:PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.
Receive News & Ratings for Perrigo Company PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.